| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |